These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13294645)

  • 1. [Experience with venogal, a substance in vitro; the effect on the thrombelastogram, plasmathromboplastin, plasma-antithrombin and the heparin tolerance test].
    KELLER M
    Gynaecologia; 1955 Dec; 140(6):387-92. PubMed ID: 13294645
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES ON THROMBIN INACTIVATION IN NORMAL PLASMA, SERUM AND PLASMA FRACTIONS, AND ITS RELATION TO HEPARIN.
    BLOMBAECK B; BLOMBAECK M; OLSSON P
    Thromb Diath Haemorrh; 1963 Jul; 143():368-86. PubMed ID: 14081260
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
    Krulder JW; Strebus AF; Meinders AE; Briët E
    Haemostasis; 1996; 26(2):85-9. PubMed ID: 9119287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the antithrombin and heparin cofactor activities of a fraction adsorbed from plasma by aluminum hydroxide.
    MONKHOUSE FC; FRANCE ES; SEEGERS WH
    Circ Res; 1955 Jul; 3(4):397-402. PubMed ID: 14390722
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of heparin on prothrombinic activity, on circulatory anticoagulants (antithromboplastin, plasma and serum antithrombin, antifibrinogen, on utilization of prothrombin, on conversion and acceleration factors in prothrombin conversion, on proteinemia, and on protein fraction].
    MARRAZZA P; DI GIROLAMO L
    Arch Sci Med (Torino); 1952 Jan; 93(1):9-16. PubMed ID: 14944438
    [No Abstract]   [Full Text] [Related]  

  • 6. [On serum and heparin antithrombin].
    JANUSZKO T
    Postepy Hig Med Dosw; 1961; 15():297-312. PubMed ID: 13789521
    [No Abstract]   [Full Text] [Related]  

  • 7. [A HEPARIN-TYPE ANTITHROMBIN IN A GAMMA-MYELOMA. CONSIDERATIONS ON SPONTANEOUS ANTICOAGULANTS IN KAHLER'S DISEASE].
    FAVRE-GILLY J; CREYSSEL R; THOUVEREZ JP; REVOL L; CROIZAT P
    Hemostase; 1963; 3():325-33. PubMed ID: 14151020
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies upon the relation between plasma antithrombin and heparin; influence of plasma antithrombin on prothrombin time.
    TANTURI CA; WETZEL NC
    Am J Med Sci; 1949 Apr; 217(4):410-20. PubMed ID: 18115156
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasmatic cofactor of heparin and its relations with antithrombin].
    LOEB J
    Arch Sci Physiol (Paris); 1956; 10(2):129-42. PubMed ID: 13341284
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative aspects of antithrombin and heparin in plasma.
    WAUGH DF; FITZGERALD MA
    Am J Physiol; 1956 Mar; 184(3):627-39. PubMed ID: 13302473
    [No Abstract]   [Full Text] [Related]  

  • 11. Biologic actions of heparin.
    Rosenberg RD
    Semin Hematol; 1977 Oct; 14(4):427-40. PubMed ID: 144323
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antithrombin and heparin].
    NOLF P
    Arch Int Physiol; 1951 Feb; 58(4):441-4. PubMed ID: 14811565
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombin Dosing Guidelines in Children Underestimate Dose Needed for Plasma Level Increase.
    Mattke AC; Johnson KE; Parker S; Stocker C; Gibbons K; Schibler A
    Pediatr Crit Care Med; 2020 Aug; 21(8):746-752. PubMed ID: 32452976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progressively acting antithrombins and plasma heparin resistance in ischemic heart disease].
    Barkagan ZS; Bishevskiĭ KM; Vidiakov GE; Kungurov IA
    Kardiologiia; 1981 Aug; 21(8):31-5. PubMed ID: 7289382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative performance of three anti-factor Xa heparin assays in patients in a medical intensive care unit receiving intravenous, unfractionated heparin.
    Lehman CM; Rettmann JA; Wilson LW; Markewitz BA
    Am J Clin Pathol; 2006 Sep; 126(3):416-21. PubMed ID: 16880140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombin time and antithrombin power of human plasma in the presence of heparin and some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    J Physiol (Paris); 1955; 47(1):115-7. PubMed ID: 13243272
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel antithrombin-heparin covalent complex: antithrombotic and bleeding studies in rabbits.
    Chan AK; Berry L; Klement P; Julian J; Mitchell L; Weitz J; Hirsh J; Andrew M
    Blood Coagul Fibrinolysis; 1998 Oct; 9(7):587-95. PubMed ID: 9863706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behaviour of antithrombin III abnormalities in the crossed immunoelectrophoresis system.
    Girolami A; Cappellato G; Vicarioto MA; Vergolani A; Traverso R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):159-64. PubMed ID: 2581861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A kinetic study on the effects of anticoagulants on the interaction of fibrinogen and thrombin.
    Nakanishi E; Sato H; Nakajima A
    J Biomed Mater Res; 1987 Feb; 21(2):187-200. PubMed ID: 2434508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANTITHROMBIN ACTIVITY (HEPARIN CO-FACTOR) IN PLASMA AFTER MAJOR SURGERY IN HEPARINIZED PATIENTS.
    OLSSON P; VON FRANCKEN ; NORDSTROEM S
    Acta Chir Scand; 1964 Jun; 127():578-83. PubMed ID: 14175132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.